[ad_1]
According to the agency, in three cases the complications were serious: the patients experienced an allergic reaction or anaphylactic shock. According to the agency, such a number of side effect reports could have been expected, but predicting what the future will look like so far is difficult.
According to the National Institute for Health and Social Development on Tuesday, 45,000 have received the first dose of the vaccine in Finland so far. people.
According to the institute, the vaccination of the entire Finnish population could last the entire year 20021. By the summer, the country will receive 5 to 7 million doses of the vaccine, which will be vaccinated with 2.5 to 3.5 million. people (out of a population of about 5.5 million).
Vaccination with a product developed by the American company Pfizer and its partner in Germany, BioNTech, began in Finland on December 27 last year. No other vaccines have yet been shipped to the country.
No part of this publication may be reproduced without the written permission of ELTA.
[ad_2]
